All In MedTech

Device Trial Radar · NCT05208905

LIFE-BTK PK Sub-study

LIFE-BTK Pharmacokinetics (PK) Sub-study

Last checked: Nov 20, 2026Latest source record: Jan 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

9

Actual

Start

Feb 10, 2022

Primary completion

Apr 18, 2023

Study completion Feb 22, 2028

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jan 26, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

LIFE-BTK PK is a prospective, single-arm, open-label, non-blinded, non-randomized sub-study of LIFE-BTK Randomized Controlled Trial (NCT04227899), that will enroll approximately 7 subjects in the United States (US) and outside the US with a maximum of 5 sites in the US. Of the 7 subjects planned to be enrolled, 4 subjects will be treated with Esprit BTK in below the knee artery(ies) in whom drug-coated balloons (DCB) were not used; 3 subjects will be treated with Esprit BTK in below the knee artery(ies) in whom DCB were used for treatment of inflow disease.

Conditions

  • Critical Limb Ischemia (CLI)

Interventions

  • Esprit BTK DeviceDevice

    Participants will receive Esprit BTK Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximal Blood Everolimus Concentration (Cmax)Time frame: 0 to 60 days
  2. Area Under the Blood Concentration Time Curve From Administration to the Concentration at 24 Hours (AUC0-24h)Time frame: 0 to 24 hours
  3. Area Under the Blood Concentration Time Curve From Administration to Last Observed Concentration at Time t (AUCt)Time frame: 0 to 60 days

3 more outcomes with a free account

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • First Coast Cardiovascular Institute

    Jacksonville, Florida

  • Charlton Memorial Hospital

    South Dartmouth, Massachusetts

  • Ascension St. John Jane Phillips

    Bartlesville, Oklahoma

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.